A battle is brewing in the HIV research world about the best way to prevent HIV transmission. On one side are drugs that target the tissue where exposure to the virus occurs — think a gel or douche. On the other is a whole-body approach. Think a pill or a shot.
At the heart of the debate is a tall, square-jawed scientist in wire-rimmed glasses who still carries himself like a military man: Dr. Craig Hendrix. Hendrix’s career has touched every part of the HIV prevention world. He’s analyzed da...
When people started to show up to Dr. William Cooke's primary care office in Austin, Ind., in 2014 with HIV, Cooke knew it was probably related to the region's opioid epidemic. But what he and the rest of the public health community didn't know was who they were missing or how long the HIV outbreak had been going on.
Now they've got a clearer picture — literally. In visualizations published in the Journal of Infectious Diseases, dots and lines define the constellations of Indiana's HIV outbre...
Physician leaders know about the potential dangers of opioid prescriptions for pain, and they’re open to new ideas. But while federal agencies encourage that thinking, they’re not as forthcoming with practical support.
Ann Lindsay, MD, cares for people with complex conditions — people with an average of nine conditions and lots of medications. Often, they have pain. And often, when they first enroll in her clinic, they are on an opioid pain reliever.
So when Lindsay and her husband, Alan Glas...
"There's an ethical obligation to ensure that young, black MSM, including those in observational studies, have access to the best possible HIV prevention package, which includes PrEP," she said. "The South can really benefit from the examples of New York City and San Francisco, and it would be wonderful if we had something similar to what Washington State has, something like an [AIDS Drugs Assistance Program] for PrEP. But you have to have the political will."
Tenofovir/emtricitabine (TDF/FTC, Truvada) is effective for preventing HIV transmission in teenagers, but high rates of non-adherence mean that the answer for youth HIV risk can't just be biomedical, according to the findings of a study released this month in the journal JAMA Pediatrics.
"[This study] tells us that [pre-exposure prophylaxis, or] PrEP is safe and should be made available to adolescent men who have sex with men [MSM] who are vulnerable to HIV infection,...
"What we see is that it doesn't matter if you're in a southern or a northern state, in a state that expanded Medicaid or didn't, whether you're in a state that had access to [pre-exposure prophylaxis] or not," Millett told Medscape. "The number of new infections fell when you followed a small set of proven interventions."
What it didn't make clear is that either effective treatment for the partner living with HIV or pre-exposure prophylaxis (PrEP) for the negative partner is sufficient on its own to prevent transmission during baby making.
And HIV-affected families have noticed....
"I went from being on the verge of quitting to having a pretty big state and national role,"
Lives Won't Wait: A Day in the Life of a Syringe Exchange - HIV Prevention Resource Center - TheBody.com
Lives Won't Wait: A Day in the Life of a Syringe Ex...
An unconventional team of doctors figured out how to provide high-need university employees with better health care, for less money
What if you took the concept of an intensive care unit—a single location that pulls together all the personnel and technology needed to care for the sickest patients in a hospital—and applied it to patients who were well enough not to be in the hospital but a lot sicker than the average patient in a primary care doctor’s practice?
Harnessing Vaginal Microbiota to Protect Women From HIV: What We Know and Don't Know - TheBodyPRO.com
"I would love at some point in my career," Scott McClelland said, "to be able to say that we need to control asymptomatic BV."
'Stop Describing, Start Intervening': Can the CDC's New Viral Load Data Help Guide HIV Programs? - TheBodyPRO.com
"The main message here is that, overall, we saw improvements for the whole population, suggesting that the efforts to test [and] diagnose HIV infection sooner, start [antiretroviral] treatment earlier and help patients be retained in care and adherent to their treatment are working over time," Buchacz told TheBodyPRO.com. "I think that's good news."